Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
SN BioScience
SN BioScience
Cancer Research and Biostatistics Clinical Trials Consortium
Daiichi Sankyo
National Cancer Institute (NCI)